Oliver Sol

Chief Tech/Sci/R&D Officer at AC IMMUNE SA

58 year

Health Technology

Consumer Services

Profile

Oliver Sol is currently working as the VP & Head-Clinical Development at AC Immune SA. Previously, he worked as the Clinical Director at Exonhit and as the Director-Medical & Regulatory Affairs at Eurobio-Scientific SA. Dr. Sol holds a doctorate degree from Université de Paris XI Paris Sud.

Oliver Sol active positions

Companies	Position	Start
AC IMMUNE SA	Chief Tech/Sci/R&D Officer	-

All active positions of Oliver Sol

Former positions of Oliver Sol

Companies	Position	End
EUROBIO SCIENTIFIC	Chief Tech/Sci/R&D Officer	-
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Chief Tech/Sci/R&D Officer	-

See the detail of Oliver Sol's experience

Training of Oliver Sol

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Oliver Sol's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
AC IMMUNE SA	Health Technology
EUROBIO SCIENTIFIC	Health Technology

Private companies	2
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Health Technology
Université de Paris XI Paris Sud	Consumer Services